I was very surprised that swabbing method was approved back in April. In my opinion it was a knee-jerk approval due to the hysteria at the time because so much was unknown and the absolute lack of testing capacity was staring all of us in the face.
I understand it was primarily done because people aren't willing to self collect a deeper sample, and there were huge concerns about the PPE required to do a proper NP swab (since it often makes people sneeze), but using a nares or anterior nares swab for diagnosis of a respiratory virus is very inconsistent at best.
My lab works closely with a clinical respiratory virus diagnostic lab (they run a panel for 21 different respiratory viruses). We've run a ton of combinations over the years of swab styles/sizes, swab materials, swabbing depths (nares, mid-turbinate, nasopharyngeal, oropharyngeal, etc..) for multiple respiratory viruses to compare the impact of sampling on test results.
FWIW, swabbing as shown in that video greatly increases the number of false negatives on all viruses we've tested, though we have not specifically tested SARS-CoV-2 patients.
If you read Labcorp's emergency use authorization submission to the FDA, they don't even test samples collected this way. They use NP swabs to validate their assay and set the test limit of detection. They then "validate" home collection by having people collect the swabs on themselves as shown in the video, and then randomly spike in virus to show that it survives transit through the mail.
They never test whether a nares swab vs. an NP swab has an impact. And those of us that have looked know it can make a huge difference.
anyway, no point. Your link just reminded of that whole situation.